-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$55.20-7.95% Downside
Rhythm Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. has been rated by research analysts at Needham, Goldman Sachs, H.C. Wainwright, JMP Securities, Stifel Nicolaus in the past 90 days.